Development and validation of UV-visible spectrophotometric baseline manipulation method for simultaneous quantitation of tenofovir disoproxil fumarate and emtricitabine in pharmaceutical dosage form

5Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A simple, economical, precise, and accurate new UV-visible spectrophotometric baseline manipulation method for simultaneous determination of tenofovir disoproxil fumarate (TE) and emtricitabine (EM) in combined tablet dosage form has been developed. The method is based on baseline manipulation (difference) spectroscopy where amplitudes at 261 and 289.9 nm were selected to determine TE and EM, respectively, in combined formulation, and distilled water was used as solvent. Both drugs obey Beer's law in the concentration ranges of 4-20 g/mL for TE and 6-30 g/mL for EM. The results of analysis have been validated statistically, and recovery studies confirmed the accuracy of the proposed method which was carried out by following the ICH guidelines. © 2013 Vishnu P. Choudhari et al.

Cite

CITATION STYLE

APA

Choudhari, V. P., Parekar, S. R., Chate, S. G., Bharande, P. D., Singh, R. R., & Kuchekar, B. S. (2013). Development and validation of UV-visible spectrophotometric baseline manipulation method for simultaneous quantitation of tenofovir disoproxil fumarate and emtricitabine in pharmaceutical dosage form. Journal of Spectroscopy, 1(1). https://doi.org/10.1155/2013/146580

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free